Fiji vs Netherlands: Antiretroviral therapy coverage for PMTCT
Fiji
57.0%
in 2024
Netherlands
55.0%
in 2009
Fiji rank
63rd
Netherlands rank
64th
Antiretroviral therapy coverage for PMTCT over time
- Fiji
- Netherlands
How they compare
Fiji currently reports 57.0% against 55.0% in Netherlands, a difference of 2.0%.
The two have swapped places 1 time across 10 shared years of data; in 2000 it was Netherlands ahead.
Fiji ranks 63rd and Netherlands ranks 64th of 84 countries.
Netherlands has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Fiji or Netherlands?
- Fiji, at 57.0% against 55.0% in Netherlands as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Fiji and Netherlands?
- 2.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Netherlands?
- 10 years are reported by both, from 2000 to 2009.
- How do Fiji and Netherlands rank globally for antiretroviral therapy coverage for pmtct?
- Fiji ranks 63rd and Netherlands ranks 64th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).